Evidence map›Paper›PMID 41810332›Full record

ArticleInternational journal of breast cancer2026

Association of Chewing Tobacco and the Risk of Breast Cancer in Indian Women: A Multicentre Case-Control Study.

Romi Moirangthem, Ankita Manjrekar, Gayathri B Pullat, Shruti Vishwas Golapkar, Ruchita Sahdev Margale, Sakshi Sagare, Dipakshi Talukdar, Nandini Chakraborty, Ruchi Pathak, Satyajit Pradhan and 6 more

Abstract read
In one paragraph

Article in International journal of breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Romi MoirangthemDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Ankita ManjrekarDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Gayathri B PullatDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Shruti Vishwas GolapkarDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Ruchita Sahdev MargaleDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Sakshi SagareDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.
Dipakshi TalukdarDepartment of Medical and Paediatric Oncology, Dr. B. Borooah Cancer Institute-Tata Memorial Centre, Guwahati, India.
Nandini ChakrabortyClinical Research Secretariat, Dr. B. Borooah Cancer Institute-Tata Memorial Centre, Guwahati, India.
Ruchi PathakDepartment of Epidemiology and Community Screening, Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, Uttar Pradesh, India.
Satyajit PradhanHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India, hbni.ac.in.
Manigreeva KrishnatreyaDepartment of Cancer Registry and Epidemiology, Dr. B. Borooah Cancer Institute-Tata Memorial Centre, Guwahati, India.
Nandkumar PanseDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Nargis Dutt Memorial Cancer Hospital, Solapur, Maharashtra, India, tmcepi.gov.in.
Rajesh DikshitHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India, hbni.ac.in.
Isabelle SoerjomataramCancer Surveillance Branch, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France, who.int.ORCID https://orcid.org/0000-0002-6017-741X
Sudeep GuptaHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India, hbni.ac.in.ORCID https://orcid.org/0000-0002-6742-6378
Sharayu MhatreDivision of Molecular Epidemiology and Population Genomics, Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai, Maharashtra, India, tmc.gov.in.ORCID https://orcid.org/0000-0001-7072-802X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Even though breast cancer (BC) is the most common female cancer worldwide, the role of tobacco, specifically chewing tobacco in the development of BC has not been widely studied. This study is aimed at assessing this association. Methods: A multicentre hospital-based case-control study was utilised. Two thousand five hundred fifty-three histopathologically confirmed BC cases, and 2239 visitor controls were included. Self-reported information was collected regarding tobacco consumption and other potential confounders. A logistic regression model was used to calculate odds ratio (OR) and its 95% confidence interval (CI), after adjusting for age, current residential region, education, various reproductive factors, BMI and history of benign breast lump. Attributable fraction (AF) and population attributable fraction (PAF) of BC due to chewing tobacco were also calculated. Results: An increased risk of BC was observed in women who ever used chewing tobacco (OR:1.19, 95% CI:1.00-1.41) as compared to those who never consumed tobacco (smoking and chewing), consistent across all subtypes of BC. A dose-response relation was observed for duration of tobacco chewing (OR Conclusion: Our study suggests that chewing tobacco is associated with an increased risk of BC for all subtypes. This is particularly true when the duration of exposure is higher and exposure begins before FFTP. This highlights the need to target tobacco control policies to smokeless tobacco along with smoking, thus reducing the burden of BC to some extent.

Indexed as

breast carcinomasmokeless tobaccospit tobacco

Identifiers

PMID41810332
PMCPMC12969211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.